【摘 要】
：
Recently, application of tissue engineering products has been rapidly developed by new strategy.That is in vivo tissue engineering where the used cells are taken from patents body himself.
【机 构】
：
Institute for Regenerative Medical Materials,School of Materials Science and Engineering,Tsinghua Un
【出 处】
：
2013 Annual Meeting of the Asia Pacific Chapter of the Tissu
论文部分内容阅读
Recently, application of tissue engineering products has been rapidly developed by new strategy.That is in vivo tissue engineering where the used cells are taken from patents body himself.
其他文献
Numbers of different types of dressings can be used during the healing process of a single wound.For example, the commercial products of OpSite? and Tegaderm? are sterile semipermeable film of polyure
With recent scientific development, various biosignaling molecules have been available for tissue regeneration therapy.If a key molecule can be supplied to the right place at right time period and con
Tissue engineering and regenerative medicine has emerged as an alternative and effective technique to regenerate damaged or disabled tissues.
Low back pain is a common condition in the Western world and intervertebral disc degeneration is considered a major cause.Disc degeneration is characterized by dysfunctional cells, reduced disc height
Introduction: The field of cell therapy, tissue engineering and regenerative medicine is allowing scientists to engineer organs and tissues by growing patients own cells.
In vitro culture of primary cells typically involves monolayer expansion on tissue culture plastic and serial replating of the cells onto new dishes upon confluence.
Objectives: Transplantation of mesenchymal stem cell (MSC) after cerebral ischemia has been shown to improve functional recovery.However, the migration, distribution and survival of grafted MSCs in is
Non-invasive, whole body imaging will play a key role in evaluating the outcome of clinical trials involving regenerative medicine, be it stem cells, scaffolds, artificial organs, or all of these comb
ISO/TC150 (International Organization for Standardization/Implants for surgery) has established a new subcommittee SC7 (TEMPS: Tissue engineered medical products) in 2007 proposed by Japan.
Prior to clinical translation extensive testing procedures are necessary, as laid down by the regulatory authorities.An all-prevading question in this scenario is whether the test systems adopted, whe